Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Witty

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Progress in Medicinal Chemistry|April 23, 2018
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|April 24, 2012
The large scale restructuring of pharmaceutical company research function. PrefaceG Lawton, David R Witty
Progress in Medicinal Chemistry|February 7, 2013
Glucokinase. PrefaceGeoff Lawton, David R Witty
Progress in Medicinal Chemistry|April 12, 2011
Drug discovery projects. PrefaceG Lawton, David R Witty
Progress in Medicinal Chemistry|May 5, 2020
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|June 26, 2022
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|June 20, 2021
PrefaceDavid R Witty, Brian Cox
Current Topics in Medicinal Chemistry|September 28, 2007
Biphenyl amides and isosteres as MCH R1 antagonistsDonald L Hertzog, David R Witty
Bioconjugate Chemistry|July 27, 2022
Gold-Mediated Multiple Cysteine Arylation for the Construction of Highly Constrained Bicycle PeptidesGemma E Mudd, Steven J Stanway, David R Witty, et al.
Protein Science : a Publication of the Protein Society|June 19, 2013
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug designOnkar Singh, Anthony Shillings, Peter Craggs, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Progress in Medicinal Chemistry|April 23, 2018
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|April 24, 2012
The large scale restructuring of pharmaceutical company research function. PrefaceG Lawton, David R Witty
Progress in Medicinal Chemistry|February 7, 2013
Glucokinase. PrefaceGeoff Lawton, David R Witty
Progress in Medicinal Chemistry|April 12, 2011
Drug discovery projects. PrefaceG Lawton, David R Witty
Progress in Medicinal Chemistry|May 5, 2020
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|June 26, 2022
PrefaceDavid R Witty, Brian Cox
Progress in Medicinal Chemistry|June 20, 2021
PrefaceDavid R Witty, Brian Cox
Current Topics in Medicinal Chemistry|September 28, 2007
Biphenyl amides and isosteres as MCH R1 antagonistsDonald L Hertzog, David R Witty
Bioconjugate Chemistry|July 27, 2022
Gold-Mediated Multiple Cysteine Arylation for the Construction of Highly Constrained Bicycle PeptidesGemma E Mudd, Steven J Stanway, David R Witty, et al.
Protein Science : a Publication of the Protein Society|June 19, 2013
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug designOnkar Singh, Anthony Shillings, Peter Craggs, et al.
Pageof 2